bito's, page-21

I wouldn't expect much action from buyers for a little while as most who want more will have taken up options.

I wonder if management have been holding off on making a deal with a big pharma until after the options cap raising? They may have a little more leverage for a joint venture or partnership with $ in the bank. I hope so.

There are still the .20c options (6,418,049) outstanding due by 30 March. I expect the management would like to see the sp over .20 before then so that many of these ones may be excercised as well.

I see also that Michelle Miller has 5mil options some at .22 & others at .25 due by 30/10/2015. No doubt she'd like to see the sp well over that before too long so she can get a good return by taking up some of her options from time to time.

... With hope, looking forward to an announcement on some kind of a deal before the end of March to send this way up!